To effectively tame Malaria in Kano state, the Kano state government in collaboration with Malaria Consortium will spend over Three Billion Naira (N3b) in the state.
The state governor Dr. Abdullahi Umar Ganduje made this known when he Inaugurated Malaria Chemoprevention along with Maternal Newborn and Child Health Week, for the 44 local governments of the state, in Bichi local council.
Also in an attempt to avoid sole concentration on COVID-19 pandemic at the expense of all other illnesses, in driving effective response, governor Ganduje said that event was necessary for the continued support and development for the health sector.
Read also:BDC with links to Magu Transacted 500 Billion Naira
“It is glaring that global attention is turned to COVID-19 pandemic. We are witnessing the same situation across the country. This, we think should be revisited. That is why we are coming up with this and similar programs. We need to also give our attention to other illnesses,” he reminded.
“This program is aimed at saving our pregnant women and children. Pregnant women should bring themselves for this opportunity and bring forth their children. People should cooperate with the government to improve the healthcare system,” governor Ganduje said.
Read also:Kano approves 1,000 hectares for fodder production
In a statement signed by the Chief press secretary to the governor said the state Commissioner of Health, Dr. Aminu Ibrahim Tsanyawa reveals “There are estimated 219 million cases of Malaria worldwide. Most of these cases were in the African region, with an estimated 200 Million making up to 92% of global cases.”
Adding that “In 2017 five countries accounting for nearly half of all Malaria cases worldwide were in Africa. And Nigeria alone is contributing 25% of the global burden. With most childhood malarial disease and deaths occurring in the Sahel sub-region.”
He explained further that, “The MNCH Week will be conducted in all the 44 LGAs in Kano state in four cycles of 4 days per month, from July to October 2020. The exercise entails the administration of Sulfadoxine-pyrimethamine plus Amodiaquine (SPAQ) to children of 3 to 59 months. And therefore targeted 2,835,462 children in the state.”
